J A O'Brien

1.0k citations
23 papers · 881 · h-index 12

Impact in

  • Virology top 1%
    • HIV Research and Treatment
  • Infectious Diseases top 2%
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

  • Infectious Diseases 9
    • HIV/AIDS drug development and treatment 9
    • HIV/AIDS Research and Interventions 2
  • Physiology 9
    • Pain Mechanisms and Treatments 6
Co-authors
Mark E. Goldman (9 shared papers)J. M. HOFFMAN (7 shared papers)William A. Schleif (6 shared papers)J C Quintero (4 shared papers)Jack H. Nunberg (4 shared papers)Emilio A. Emini (5 shared papers)John Wai (2 shared papers)Stanley L. Gaul (1 shared paper)
Journals
Drug Metabolism and Disposition (3 papers)Pain (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Brain Behavior & Immunity - Health (1 paper)Journal of Neuroimmune Pharmacology (1 paper)
Partner nations
United StatesAustraliaAustria

In The Last Decade

J A O'Brien

20 papers receiving 856 citations

Peers

J A O'Brien
Comparison fields: 5 of 69
  • Virology 568
  • Infectious Diseases 606
  • Epidemiology 171
  • Biological Psychiatry 12
  • Organic Chemistry 105
Replace Eugene L. Asahchop with:
Eugene L. Asahchop Canada
Leila B. Giron United States
R. Tal Israel
Patricia Prodanovich United States
Fabao Zhao China
Susan P. Colby-Germinario Canada
Maria Veneziano Italy
Mohammad-Ali Jenabian Canada
Shunyao Liao China
Yabo Ouyang China
J A O'Brien relative to Eugene L. Asahchop Canada Eugene L. Asahchop's profile →
Citations per field
00.5×2×3×3.9×
Eugene L. Asahchop · 1×
Citations per year

Countries citing papers authored by J A O'Brien

Since Specialization
Citations

This map shows the geographic impact of J A O'Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A O'Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A O'Brien more than expected).

Fields of papers citing papers by J A O'Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A O'Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A O'Brien. The network helps show where J A O'Brien may publish in the future.

Co-authors

The 25 scholars most cited alongside J A O'Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J A O'Brien Line = papers co-authored together J A O'Brien links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors
Journal of Virology ·Jack H. Nunberg, William A. Schleif, Evelyn Boots, J A O'Brien, J C Quintero, J. M. HOFFMAN, Emilio A. Emini, Mark E. Goldman
1991326
2
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
Proceedings of the National Academy of Sciences ·Mark E. Goldman, Jack H. Nunberg, J A O'Brien, J C Quintero, William A. Schleif, Kurt Freund, Stanley L. Gaul, Walfred S. Saari, John Wai, J. M. HOFFMAN
1991257
3
Antibody Class and Subclass Responses to Pneumococcal Polysaccharides following Immunization of Human Immunodeficiency Virus-Infected Patients
The Journal of Infectious Diseases ·Paul J. Carson, Ronald Schut, Mindy Simpson, J A O'Brien, E. N. Janoff
199559
4
L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro
Antimicrobial Agents and Chemotherapy ·Mark E. Goldman, J A O'Brien, T L Ruffing, Jack H. Nunberg, William A. Schleif, J C Quintero, Peter K. S. Siegl, J. M. HOFFMAN, Anthony M. Smith, Emilio A. Emini
199234
5
Effect of Photobiomodulation in Rescuing Lipopolysaccharide-Induced Dopaminergic Cell Loss in the Male Sprague–Dawley Rat
Biomolecules ·J A O'Brien, Paul J. Austin
201932
6
Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist.
Journal of Pharmacology and Experimental Therapeutics ·David L. Williams, Kathryn L. Murphy, Nancy A. Nolan, J A O'Brien, Douglas J. Pettibone, Salah D. Kivlighn, Stephen M. Krause, Edward V. Lis, Gloria J. Zingaro, Robert A. Gabel
199531
7
Kynurenine, Tetrahydrobiopterin, and Cytokine Inflammatory Biomarkers in Individuals Affected by Diabetic Neuropathic Pain
Frontiers in Neuroscience ·Ananda Staats Pires, Benjamin Heng, Vanessa Tan, Alexandra Latini, Marc Russo, Danielle M. Santarelli, Dominic Bailey, Katie Wynne, J A O'Brien, Gilles J. Guillemin, Paul J. Austin
202028
8
Long-term histologic and mechanical results of a Permacol™ abdominal wall explant
Hernia ·J A O'Brien, Ronald A. Ignotz, Richard D. Montilla, Genevieve Broderick, Alexander Christakis, R. Dunn
201028
9
A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors
Antimicrobial Agents and Chemotherapy ·Mark E. Goldman, J A O'Brien, T L Ruffing, William A. Schleif, Vinod Sardana, V W Byrnes, Jon H. Condra, J. M. HOFFMAN, Emilio A. Emini
199325
10
T lymphocyte and monocyte subsets are dysregulated in type 1 diabetes patients with peripheral neuropathic pain
Brain Behavior & Immunity - Health ·J A O'Brien, Helen M. McGuire, Diana Shinko, Barbara Fazekas de St Groth, Marc Russo, Dominic Bailey, Danielle M. Santarelli, Katie Wynne, Paul J. Austin
202115
11
Machine learning analysis of the UK Biobank reveals prognostic and diagnostic immune biomarkers for polyneuropathy and neuropathic pain in diabetes
Diabetes Research and Clinical Practice ·Michael Allwright, Jackson F. Karrasch, J A O'Brien, Boris Guennewig, Paul J. Austin
202311
12
Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.
Drug Metabolism and Disposition ·Suresh K. Balani, Steven M. Pitzenberger, L R Kauffman, Byron H. Arison, Harri G. Ramjit, Mark E. Goldman, J A O'Brien, Jasia King, J. M. HOFFMAN, C. S. ROONEY
199211
13
Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
Drug Metabolism and Disposition ·Suresh K. Balani, L R Kauffman, Byron H. Arison, Timothy Olah, Mark E. Goldman, S Varga, J A O'Brien, Harri G. Ramjit, C. S. ROONEY, J. M. HOFFMAN
19947
14
ChemInform Abstract: Synthesis of a Series of 4‐(Arylethynyl)‐6‐chloro‐4‐cyclopropyl‐3,4‐ dihydroquinazolin‐2(1H)‐ones as Novel Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors.
ChemInform ·Thomas J. Tucker, Terry A. Lyle, Catherine M. Wiscount, Susan F. Britcher, Steven D. Young, William M. Sanders, William C. Lumma, Mark E. Goldman, J A O'Brien, Richard G. Ball, Carl F. Homnick, William A. Schleif, Emilio A. Emini, Joel R. Huff, Paul Anderson
19945
15
Minocycline Abrogates Individual Differences in Nerve Injury-Evoked Affective Disturbances in Male Rats and Prevents Associated Supraspinal Neuroinflammation
Journal of Neuroimmune Pharmacology ·J A O'Brien, Paul J. Austin
20244
16
Nerve–myeloid cell interactions in persistent human pain: a reappraisal using updated cell subset classifications
Pain ·J A O'Brien, Jackson F. Karrasch, Yun Huang, Erica E. Vine, Anthony L. Cunningham, Andrew N. Harman, Paul J. Austin
20232
17
Photobiomodulation in the infrared spectrum reverses the expansion of circulating natural killer cells and brain microglial activation in Sanfilippo mice
Journal of Neurochemistry ·Adeline A. Lau, K. Jin, Helen Beard, T. Windram, Keliang Xie, J A O'Brien, Daniel Neumann, Barbara King, Marten F. Snel, Paul J. Trim, John Mitrofanis, Kim M. Hemsley, Paul J. Austin
20242
18
Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
Drug Metabolism and Disposition ·Suresh K. Balani, Mark E. Goldman, L R Kauffman, S Varga, J A O'Brien, Sheri Smith, Timothy Olah, Harri G. Ramjit, Terry W. Schorn, Steven M. Pitzenberger
19932
19
10-kHz High-Frequency Spinal Cord Stimulation Significantly Reduces Proinflammatory Cytokines and Distinct Populations of T Lymphocytes in Patients With Persistent Spinal Pain Syndrome Type 2
Neuromodulation Technology at the Neural Interface ·Stefanie S Kogias, J A O'Brien, Rebecca V Robertson, Peng An, Fernando A Tinoco-Mendoza, Alister Ramachandran, Luke A. Henderson, Paul J. Austin
20251
20
ChemInform Abstract: 2‐Pyridinone Derivatives: A New Class of Nonnucleoside, HIV‐1‐Specific Reverse Transcriptase Inhibitors.
ChemInform ·Walfred S. Saari, J. M. HOFFMAN, John Wai, Thorsten E. Fisher, C. S. ROONEY, Anthony M. Smith, C. M. Thomas, Mark E. Goldman, J A O'Brien, Jack H. Nunberg, J C Quintero, William A. Schleif, Emilio A. Emini, Andrew M. Stern, Paul Anderson
19921

About J A O'Brien

J A O'Brien is a scholar working on Infectious Diseases, Physiology, Virology, Molecular Biology and Psychiatry and Mental health, having authored 23 papers that have together received 881 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), Pain Mechanisms and Treatments (6 papers), HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (2 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Laser Applications in Dentistry and Medicine (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Virology (568 citations), Infectious Diseases (606 citations), Epidemiology (171 citations), Biological Psychiatry (12 citations) and Organic Chemistry (105 citations). J A O'Brien has collaborated with scholars based in United States, Australia and Austria. Frequent co-authors include Mark E. Goldman, J. M. HOFFMAN, William A. Schleif, J C Quintero, Jack H. Nunberg, Emilio A. Emini, John Wai, Stanley L. Gaul, Walfred S. Saari and Paul J. Austin. Their work appears in journals such as Drug Metabolism and Disposition, Pain, Antimicrobial Agents and Chemotherapy, Brain Behavior & Immunity - Health and Journal of Neuroimmune Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugene L. AsahchopBreakdown of academic impact, for papers by Leila B. GironBreakdown of academic impact, for papers by R. TalBreakdown of academic impact, for papers by Patricia ProdanovichBreakdown of academic impact, for papers by Fabao ZhaoBreakdown of academic impact, for papers by Susan P. Colby-GerminarioBreakdown of academic impact, for papers by Maria VenezianoBreakdown of academic impact, for papers by Mohammad-Ali JenabianBreakdown of academic impact, for papers by Shunyao LiaoBreakdown of academic impact, for papers by Yabo Ouyang